Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Roche’s MabTherea shot gets EU OK for chronic lymphocytic leukemia

Written by: | no-reply@reuters.com | Dated: Tuesday, May 31st, 2016

 

The European Commission approved the injection for people with previously untreated and relapsed/refractory forms of the disease.

“MabThera SC provides patients with significantly faster treatment administration and the opportunity to enjoy more time outside the clinical setting compared to intravenous delivery of the medicine,” Chief Medical Officer Sandra Horning said.

 

(Reporting by Brenna Hughes Neghaiwi; Editing by Michael Shields)

Source: Reuters Health

http://www.reuters.com/article/us-roche-eu-mabthera-idUSKCN0YM0EI

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

December 2017 Focus: Ad Agency Roundtable and more!

Subscribe

Ad Right Bottom

Main Navigation